Allovir Stock Market Value
| ALVR Stock | USD 0.45 0.01 2.17% |
| Symbol | Allovir |
Allovir Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allovir. If investors know Allovir will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allovir listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Return On Assets (0.37) | Return On Equity (0.80) |
The market value of Allovir is measured differently than its book value, which is the value of Allovir that is recorded on the company's balance sheet. Investors also form their own opinion of Allovir's value that differs from its market value or its book value, called intrinsic value, which is Allovir's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allovir's market value can be influenced by many factors that don't directly affect Allovir's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allovir's value and its price as these two are different measures arrived at by different means. Investors typically determine if Allovir is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allovir's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Allovir 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Allovir's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Allovir.
| 11/15/2024 |
| 12/15/2024 |
If you would invest 0.00 in Allovir on November 15, 2024 and sell it all today you would earn a total of 0.00 from holding Allovir or generate 0.0% return on investment in Allovir over 30 days. Allovir is related to or competes with Anebulo Pharmaceuticals, Mineralys Therapeutics,, AN2 Therapeutics, Aerovate Therapeutics, Adagene, Stoke Therapeutics, and Black Diamond. Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-she... More
Allovir Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Allovir's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Allovir upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 47.97 | |||
| Value At Risk | (8.24) | |||
| Potential Upside | 6.25 |
Allovir Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Allovir's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Allovir's standard deviation. In reality, there are many statistical measures that can use Allovir historical prices to predict the future Allovir's volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.67) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (0.25) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Allovir's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Allovir Backtested Returns
Allovir secures Sharpe Ratio (or Efficiency) of -0.0714, which signifies that the company had a -0.0714% return per unit of risk over the last 3 months. Allovir exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Allovir's Standard Deviation of 7.08, risk adjusted performance of (0.04), and Mean Deviation of 3.96 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.93, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Allovir will likely underperform. At this point, Allovir has a negative expected return of -0.51%. Please make sure to confirm Allovir's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Allovir performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.42 |
Average predictability
Allovir has average predictability. Overlapping area represents the amount of predictability between Allovir time series from 15th of November 2024 to 30th of November 2024 and 30th of November 2024 to 15th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Allovir price movement. The serial correlation of 0.42 indicates that just about 42.0% of current Allovir price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.42 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Allovir lagged returns against current returns
Autocorrelation, which is Allovir stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Allovir's stock expected returns. We can calculate the autocorrelation of Allovir returns to help us make a trade decision. For example, suppose you find that Allovir has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Allovir regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Allovir stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Allovir stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Allovir stock over time.
Current vs Lagged Prices |
| Timeline |
Allovir Lagged Returns
When evaluating Allovir's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Allovir stock have on its future price. Allovir autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Allovir autocorrelation shows the relationship between Allovir stock current value and its past values and can show if there is a momentum factor associated with investing in Allovir.
Regressed Prices |
| Timeline |
Pair Trading with Allovir
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allovir position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will appreciate offsetting losses from the drop in the long position's value.Moving together with Allovir Stock
Moving against Allovir Stock
| 0.78 | DYAI | Dyadic International | PairCorr |
| 0.67 | ESPR | Esperion Therapeutics | PairCorr |
| 0.63 | BMY | Bristol Myers Squibb | PairCorr |
| 0.45 | GILD | Gilead Sciences Sell-off Trend | PairCorr |
| 0.36 | DNA | Ginkgo Bioworks Holdings | PairCorr |
The ability to find closely correlated positions to Allovir could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allovir when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allovir - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allovir to buy it.
The correlation of Allovir is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allovir moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allovir moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allovir can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Allovir Stock Analysis
When running Allovir's price analysis, check to measure Allovir's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allovir is operating at the current time. Most of Allovir's value examination focuses on studying past and present price action to predict the probability of Allovir's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allovir's price. Additionally, you may evaluate how the addition of Allovir to your portfolios can decrease your overall portfolio volatility.